During this segment, the panelists discuss the increased utilization of magnetic resonance imaging (MRI) scans and its impact in multiple sclerosis (MS).
 
Moderator Fred Lublin, MD, explains the relationship between MRI scans and radiologically isolated syndrome (RIS).
 
Although beneficial, Gary M. Owens, MD, explains that even in instances where MRI scans suggest MS, not all patients require treatment.
 
As explained by Dr Lublin, patient accessibility and affordability is also a challenge. Therefore, the panelists explain how radiology programs manage pre-approval processes for MRI scans.
 
Dr Owens concludes this segment by explaining that while many plans make it simple for patients with, or suspected of, MS to have access to MRI scans, a “broad net” is a consequence.During this segment, the panelists discuss the increased utilization of magnetic resonance imaging scans and its impact in multiple sclerosis.

Episode 16 - MRI Scans and MS

During this segment, the panelists discuss the increased utilization of magnetic resonance imaging scans and its impact in multiple sclerosis.
Published Online: January 03, 2014
During this segment, the panelists discuss the increased utilization of magnetic resonance imaging (MRI) scans and its impact in multiple sclerosis (MS).
 
Moderator Fred Lublin, MD, explains the relationship between MRI scans and radiologically isolated syndrome (RIS).
 
Although beneficial, Gary M. Owens, MD, explains that even in instances where MRI scans suggest MS, not all patients require treatment.
 
As explained by Dr Lublin, patient accessibility and affordability is also a challenge. Therefore, the panelists explain how radiology programs manage pre-approval processes for MRI scans.
 
Dr Owens concludes this segment by explaining that while many plans make it simple for patients with, or suspected of, MS to have access to MRI scans, a “broad net” is a consequence.During this segment, the panelists discuss the increased utilization of magnetic resonance imaging scans and its impact in multiple sclerosis.

View More From This Discussion
Episode 1 Episode 1 - The Changing Tides of Multiple Sclerosis: Where Do We Currently Stand?
Episode 2 Episode 2 - Elucidating the Patient's Starting Point in Care
Episode 3 Episode 3- Exploring the Etiology of Multiple Sclerosis
Episode 4 Episode 4- Characterizing Multiple Sclerosis
Episode 5 Episode 5 - Elucidating the Economic Burden of MS
Episode 6 Episode 6 - Discussing the Pathophysiology of MS
Episode 7 Episode 7 - Increased Monetary Costs of Multiple Sclerosis
Episode 8 Episode 8 - Long-Term Effects of Disease-Modifying Therapies
Episode 9 Episode 9 - Exploring Trials, Data, and the Future of Multiple Sclerosis
Episode 10 Episode 10 - Treatment Complexities
Episode 11 Episode 11 - Clinical Guidelines Vital to the Future of MS
Episode 12 Episode 12 - New MS Agents Challenged
Episode 13 Episode 13 - Treatment Challenges for Progressive Disease
Episode 14 Episode 14 - Concerns about Rising Costs of Treatment
Episode 15 Episode 15 - Controlling Drug Prices and Working at the Population Level
Episode 16 Episode 16 - MRI Scans and MS
Episode 17 Episode 17 - Conclusion: Treatment Advancements and Final Remarks
right-arrow
Related Articles

More on AJMC.COM

$vacMongoViewPlus$